32
Participants
Start Date
August 31, 2010
Primary Completion Date
August 31, 2016
Study Completion Date
January 31, 2017
Rituximab plus CHOP Immunochemotherapy
The R-CHOP treatment will continue up to 3 cycles with interval of 21 days: Each cycle consists of rituximab 375mg/m2 (iv, on day 1), cyclophosphamide 750 mg/m2 (iv, on day 1), doxorubicin 50mg/m2 (iv, on day 1), vincristine 1.4mg/m2 (iv, on day 1), and prednisolone 100mg (po, on day 1-5).
Asan Medical Center, Seoul
Lead Sponsor
Asan Medical Center
OTHER